Circulating aCL from patients with APS (but not from non-APS patients) required β2GPI as a co-factor for CL binding, and the effects of LA were shown to be sensitive to β2GPI in these patients [3–6]. This evidence concerns the gene ACLY and autoimmune polyendocrinopathy.